Please login to the form below

Not currently logged in
Email:
Password:

Zolgensma

This page shows the latest Zolgensma news and features for those working in and with pharma, biotech and healthcare.

EU authorises Roche’s spinal muscular atrophy treatment Evrysdi

EU authorises Roche’s spinal muscular atrophy treatment Evrysdi

Evrysdi becomes the third drug approved to treat the condition, following Biogen's Spinraza (nusinersen) and Novartis' Zolgensma (onasemnogene abeparvovec), and is the first that can be administered orally.

Latest news

More from news
Approximately 20 fully matching, plus 36 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics